A single-arm, multicenter, international, prospective interventional study designed to evaluate the safety and performance of an investigational device during retrograde intrarenal surgery for the treatment of renal calculi.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
75
Investigational endourological device used during retrograde intrarenal surgery.
Hospital Alemán
Buenos Aires, Argentina
Centre hospitalier de l'Universite de Montreal (CHUM)
Montreal, Canada
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Muljibhai Patel Urological Hospital
Nadiād, India
Procedure success
Successful completion of the planned procedure without device-related technical complications.
Time frame: Intraoperative
Serious Adverse Device Effects (SADEs)
Serious adverse device effects related to the investigational device.
Time frame: 30 days post-procedure
Stone-Free Status
Absence of residual stone fragments on CT imaging
Time frame: 30 days post-procedure
Stone-Free Categories
Stone-free status according to predefined categories.
Time frame: 30 days post-procedure
Intrarenal pressure assessment
Intrarenal pressure measured during the procedure.
Time frame: Intraoperative
Procedure duration
Duration of the surgical procedure.
Time frame: Intraoperative
Stone clearance
Amount of stone material removed during the procedure.
Time frame: Intraoperative
Residual stone burden
Residual stone burden assessed by imaging.
Time frame: 30 days post-procedure
Device- or procedure-related adverse event
Device- or procedure-related adverse event.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tauranga Urology Research Limited
Tauranga, New Zealand
Time frame: From procedure to 12 months post-procedure
Stone-related healthcare utilization
Healthcare utilization related to recurrent stone symptoms in the treated kidney.
Time frame: From procedure to 12 months post-procedure